Oncology in Clinical Practice

Strona główna
Polska
Warsaw
Oncology in Clinical Practice

Dane kontaktowe, mapa i wskazówki, formularz kontaktowy, godziny otwarcia, usługi, oceny, zdjęcia, filmy i ogłoszenia od Oncology in Clinical Practice, Zdrowie i medycyna, Ulica Roentgena 5, Warsaw.

25/03/2026

Diffuse gliomas with IDH mutations represent a major subgroup of brain tumors in adults. This review presents the molecular basis of these tumors and clinical evidence on vorasidenib, the first IDH1/2 inhibitor. Results from the INDIGO study showed prolonged progression-free survival, slower tumor growth, and delayed need for further treatment, while real-world data confirmed the activity and tolerability of vorasidenib in a broader patient population.

Authors: Tomasz Kubiatowski, Ewa Iżycka-Świeszewska

24/03/2026

How much do breast cancer patients in Poland pay beyond public insurance coverage? This study shows that 90.6% of respondents reported additional expenses for travel, private consultations/diagnostics, medications, dietary supplements, and rehabilitation, which they personally financed.

Authors: Mikołaj Bartoszkiewicz, Joanna Kufel-Grabowska, Zsuzsanna Beretzky, Péter Balázs, Paweł Burchardt, Valentin Brodszky

18/03/2026

This case report presents desmoplastic/nodular medulloblastoma with cervico-dorsal spinal dissemination in a 2-year-old patient. The authors describe rare co-expression of nuclear OLIG2 and nucleolar H3K27me3, offering insights into an alternative (speculative) biological interpretation.

Authors: Gabriele Gaggero, Barbara Cafferata, Chiara Trambaiolo Antonelli, Jacopo Ferro, Valerio Gaetano Vellone

16/03/2026

This case report illustrates the role of intraoperative cytology in identifying high-grade ependymoma and supporting immediate surgical decision-making, while emphasizing the value of subsequent molecular analyses in refining diagnosis, prognosis, and treatment planning in paediatric CNS tumours.

Authors: Gabriele Gaggero, Barbara Cafferata, Gianluca Piatelli, Manuela Ferraro, Valerio Gaetano Vellone

12/03/2026

How does cancer prevalence in Poland compare with other EU countries? This study analyses national and international data to assess cancer prevalence in Poland in the European context and highlights why prevalence should be used more widely when planning oncological care—because lower prevalence does not automatically mean a lower cancer burden for healthcare systems.

Authors: Joanna A. Didkowska, Urszula Wojciechowska

10/03/2026

This cross-national review of oncological data analysed epidemiology, survival, healthcare spending, screening, and access to oncology medicines across 10 European countries (Poland, Czechia, Estonia, Germany, Spain, Slovenia, the Netherlands, the United Kingdom, Italy, and Finland) using information from international sources. The authors highlight the need for multidimensional reform strategies to improve the efficiency and equity of oncology systems in Europe.

Authors: Krzysztof Nojszewski, Robert Plisko, Kaja Kostrzewska, Klaudia Janiszewska, Magdalena Władysiuk

09/03/2026

This comprehensive review evaluates the safety and efficacy of atezolizumab in patients with coexisting NSCLC and COPD. Analysis of both real-world data and randomized trials allowed the authors to conclude that atezolizumab demonstrates significant efficacy and a favorable safety profile in NSCLC patients with COPD.

Authors: Akram Hasan Kareem, Samer Imad Mohammed, Ahmed Abdali Shihad

03/03/2026

Multiple studies show that tissue trauma can activate inflammatory and molecular pathways, potentially increasing glioma invasiveness, as described in a recent review. The authors presented biological mechanisms underlying glioblastoma progression, especially in the biopsy context.

Authors: Tomasz Tykocki, Łukasz Rakasz

27/02/2026

A retrospective observational study in breast cancer patients receiving FEC chemotherapy found predictors of oral mucositis (older age, more chemotherapy cycles, NSAID use, and mucoprotective agent use) and dysgeusia/taste changes (lower albumin levels). Knowing these risk factors may help optimize supportive care, reduce oral complications, and avoid serious adverse events during systemic treatment.

Authors: Yuko Kanbayashi, Tetsuya Taguchi, Takeshi Ishikawa, Koichi Takayama

25/02/2026

A prospective observational study in 60 women receiving chemotherapy after breast cancer surgery found that more walking and moderate-intensity activity were associated with better physical and psychological quality of life, while more sedentary time was linked to lower well-being. This suggests that staying active can be a simple yet powerful part of supportive care.

Authors: Tomasz Jurys, Joanna Grupińska, Marika Wlazło, Magdalena Budzyń, Ewa Malchrowicz-Mośko, Mateusz Grajek

24/02/2026

Extraskeletal myxoid chondrosarcoma is an ultra-rare soft tissue sarcoma with a high risk of lung metastases. In two cases, repeated metastasectomies temporarily controlled the disease, but recurrences were common, and chemotherapy showed limited benefit.
Authors: Julia Wąż, Piotr Remiszewski, Mateusz Spałek, Sławomir Falkowski, Piotr Rutkowski, Anna M. Czarnecka

$Moderately hypofractionated radiotherapy (HF-M) offers an effective, shorter treatment for prostate cancer. In a retrosp...$

18/02/2026

Moderately hypofractionated radiotherapy (HF-M) offers an effective, shorter treatment for prostate cancer. In a retrospective cohort of 143 patients (mostly high-risk), HF-M delivered good biochemical control (median follow-up PSA 0.06 ng/mL) with manageable toxicity (acute toxicity 25.17%, late toxicity 37.06%; no grade 3–4 GU/GI events reported). Patient-reported outcomes highlighted quality-of-life impacts, supporting its use in everyday practice.

Authors: Javier Cifuentes-Quin, Yiselle García-Montañez, Alexandra Hurtado-Ortiz, Jhonatan Cruz, Luis Olarte-Licht, Alejandra Mendoza-Monsalve, Maricel Licht-Ardila, Edgar Fabián Manrique-Hernández

Adres

Ulica Roentgena 5
Warsaw
02-781

Strona Internetowa

https://journals.viamedica.pl/oncology_in_clinical_practice, https://www.researchgate.net/journal/Oncology-in-Clinical-P

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Oncology in Clinical Practice umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Praktyka

Wyślij wiadomość do Oncology in Clinical Practice:

Skróty

Chcesz aby twoja praktyka była na górze listy Klinika w Warsaw?

Udostępnij

Kategoria

Zdrowie i medycyna